Short-term outcomes of excisional atherectomy in lower limb arterial disease

ANZ Journal of Surgery

Volumn 87, Issue 6, 2017, Pages E1-E4

  Werner Gibbings, Keagan ^a   Dubenec, Steven ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

atherectomy; endovascular; peripheral vascular disease; revascularization; TurboHawk

Indexed keywords

AFTERCARE; AGED; ATHERECTOMY; AUSTRALIA; DEVICES; ENDOVASCULAR SURGERY; EPIDEMIOLOGY; FEMALE; HUMAN; LOWER LIMB; MALE; PATHOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; STENT; TREATMENT OUTCOME; UTILIZATION; VASCULAR PATENCY; VASCULARIZATION; VERY ELDERLY;

AFTERCARE; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; ATHERECTOMY; AUSTRALIA; ENDOVASCULAR PROCEDURES; FEMALE; HUMANS; LOWER EXTREMITY; MALE; PERIPHERAL ARTERIAL DISEASE; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 85020175728     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/ans.12897     Document Type: Article

References (22)

1. Norgren L, Hiatt WR, Dormandy JA et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur. J. Vasc. Endovasc. Surg. 2007; 33: S1–75.
2. Welfare AIoHa. Cardiovascular disease: Australian facts 2011. Cardiovascular Disease Series Cat No CVD 53 Canberra: AIHW2011.
3. Ouriel K. Peripheral arterial disease. Lancet 2001; 358: 1257–1264.
4. DeRubertis BG, Faries PL, McKinsey JF et al. Shifting paradigms in the treatment of lower extremity vascular disease: a report of 1000 percutaneous interventions. Ann. Surg. 2007; 246: 415–422.
5. Ginsburg R, Wexler L, Mitchell RS, Profitt D. Percutaneous transluminal laser angioplasty for treatment of peripheral vascular disease. Clinical experience with 16 patients. Radiology 1985; 156: 619–624.
6. Duda SH, Bosiers M, Lammer J et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J. Endovasc. Ther. 2006; 13: 701–710.
7. Tripuraneni P, Giap H, Jani S. Endovascular brachytherapy for peripheral vascular disease. Semin. Radiat. Oncol. 1999; 9: 190–202.
8. Keeling WB, Shames ML, Stone PA et al. Plaque excision with the Silverhawk catheter: early results in patients with claudication or critical limb ischemia. J. Vasc. Surg. 2007; 45: 25–31.
9. Höfling B, Pölnitz AV, Backa D et al. Percutaneous removal of atheromatous plaques in peripheral arteries. Lancet 1988; 1: 384–386.
10. Rutherford R, Becker G. Standards for evaluating and reporting the results of surgical and percutaneous therapy for peripheral arterial disease. Radiology 1991; 181: 277–281.
11. Zeller T, Rastan A, Sixt S et al. Long-term results after directional atherectomy of femoro-popliteal lesions. J. Am. Coll. Cardiol. 2006; 48: 1573–1578.
12. Schlager O, Francesconi M, Haumer M et al. Duplex sonography versus angiography for assessment of femoropopliteal arterial disease in a ‘real-world’ setting. J. Endovasc. Ther. 2007; 14: 452–459.
13. Schillinger M, Sabeti S, Loewe C et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N. Engl. J. Med. 2006; 354: 1879–1888.
14. Laird JR, Katzen BT, Scheinert D et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ. Cardiovasc. Interv. 2010; 3: 267–276.
15. Krankenberg H, Schlüter M, Steinkamp HJ et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10-cm in length the femoral artery stenting trial (FAST). Circulation 2007; 116: 285–292.
16. Duda SH, Pusich B, Richter G et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease six-month results. Circulation 2002; 106: 1505–1509.
17. Dake MD, Ansel GM, Jaff MR et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease twelve-month zilver PTX randomized study results. Circ. Cardiovasc. Interv. 2011; 4: 495–504.
18. Laird JR. Endovascular treatment of common femoral artery disease viable alternative to surgery or just another short-term fix. J. Am. Coll. Cardiol. 2011; 58: 799–800.
19. Henry M, Klonaris C, Amor M, Henry I, Tzvetanov K. State of the art: which stent for which lesion in peripheral interventions? Tex. Heart Inst. J. 2000; 27: 119–126.
20. Laird JR, Yeo KK. The treatment of femoropopliteal in-stent restenosis back to the future. J. Am. Coll. Cardiol. 2012; 59: 24–25.
21. Biskup NI, Ihnat DM, Leon LR, Gruessner AC, Mills JL. Infrainguinal atherectomy: a retrospective review of a single-center experience. Ann. Vasc. Surg. 2008; 22: 776–782.
22. Sarac TP, Altinel O, Bannazadeh M, Kashyap V, Lyden S, Clair D. Midterm outcome predictors for lower extremity atherectomy procedures. J. Vasc. Surg. 2008; 48: 885–890.